Research Funded To Date
The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
Since 2008, we have funded 33 separate institutions with over 107 different research grants totaling over $150 million. These grants have involved research in phase 0 clinical trials, biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.
2019
NATIONAL GLIOBLASTOMA AWARNESS DAY, JULY 18, 2019, MATCHING DONATION FOR THE IVY BRAIN TUMOR CENTER.
PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute
NeuroTrials, LLC
RIBOCICLIB PLUS EVEROLIMUS PHASE 0/2 CLINICAL TRIAL FOR RECURRENT GLIOBLASTOMAS.
PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological InstituteZ
NeuroTrials, LLC
UCSF PRECLINICAL CORE FOR DRUG DEVELOPMENT AT THE IVY BRAIN TUMOR CENTER.
PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute
NeuroTrials, LLC
Susan Chang, M.D.
Professor Neurological Surgery
Director Translational Research Neuro-Oncology
Director UCNS Fellowship Neuro-Oncology
Chair, CNS Tumors Site Committee UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
DEVELOPMENT OF TRIPLE-DRUG COCKTAILS TO INDUCE GLIOBLASTOMA AUTOPHAGY.
PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute
NeuroTrials, LLC
Douglas Hanahan, Ph.D.
Professor, Ecole Polytechnique Fédérale de Lausanne
Director, Laboratory of Translational Oncology
Swiss Institute for Experimental Cancer Research/Swiss Federal Institute of Technology
DAMON RUNYON CLINICAL INVESTIGATOR AWARD FUNDING RESEARCH FOR EARLY CAREER MD’S AND MD/PHDS. RESEARCH PROJECT FUNDED IS THE INVESTIGATION OF A BIOMARKR PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS.
PI: Priscilla K. Brastianos, MD
Clinical Investigator
Massachusetts General Hospital
Damon Runyon Cancer Research Foundation
NEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QUESTIONS WITHIN THE NEUROLOGICAL SCIENCES.
PI: Julie Euber
Manager of Education and Outreach
Translational Genomics Research Institute (TGen)
IMAGING TUMOR METABOLISM IN GBM PATIENTS TO HELP OPTIMIZE ANTI-TUMOR THERAPIES. THE ABILITY TO MONITOR PKM2, A KEY REGULATOR OF GBM METABOLISM, ALLOWS POTENTIAL MONITORING ESSENTIAL TO EARLY THERAPY RESPONSE.
PI: Sanjiv Sam Gambhir M.D., Ph.D.
Chair, Department of Radiology
Director, Molecular Imaging Program at Stanford
Director, Canary Center at Stanford for Cancer Early Detection
Stanford University School of Medicine